Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Oxymetazoline hydrochloride manufacturers

Filters

None products found

oxymetazoline hydrochloride

Nasal drops 0.25 mg/ml - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Portugal
Manufacturer #1858

This company, with a global presence, has been operating for over nine decades, demonstrating its experience and commitment to the healthcare industry. They provide a diverse portfolio of products, including prescription medications, healthcare solutions, and animal nutrition products. Their focus is on areas like allergies, gastrointestinal health, and immune system support. Key dosage forms include solids, liquids, and orals. They have manufacturing facilities in the EU and hold EU GMP approvals. They actively engage in research and development, investing in new molecules and clinical trials. Their commitment to sustainability is reflected in their focus on reducing environmental impact and promoting social responsibility. They operate in key regions including Europe, North America, and Latin America. While specific countries are not mentioned, the company emphasizes its international reach through a global network of partners.

Manufacturer usually replies in 14 days

oxymetazoline hydrochloride

Eye drops 0.25 mg/ml, 4 mg/ml - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Portugal
Manufacturer #1858

This company, with a global presence, has been operating for over nine decades, demonstrating its experience and commitment to the healthcare industry. They provide a diverse portfolio of products, including prescription medications, healthcare solutions, and animal nutrition products. Their focus is on areas like allergies, gastrointestinal health, and immune system support. Key dosage forms include solids, liquids, and orals. They have manufacturing facilities in the EU and hold EU GMP approvals. They actively engage in research and development, investing in new molecules and clinical trials. Their commitment to sustainability is reflected in their focus on reducing environmental impact and promoting social responsibility. They operate in key regions including Europe, North America, and Latin America. While specific countries are not mentioned, the company emphasizes its international reach through a global network of partners.

Manufacturer usually replies in 14 days

dexamethasone + oxymetazoline hydrochloride

Nasal spray 0.2028 mg + 0.5 mg/ml - 15 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Greece , Romania , Cyprus
Manufacturer #8921
A pharmaceutical manufacturer based in Europe that has been selling its products in Europe, Africa, North America, the Middle East, and CIS for 40+ years. The main therapeutic areas include oncology, allergology, and dermatology. Key production lines are Rx, medical devices, OTC, and nutraceuticals. The main dosage forms include oral solids, oral liquids, and injectables. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 10 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.